• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Prince John Michael was granted 8,977 shares, increasing direct ownership by 71% to 21,662 units (SEC Form 4)

    5/1/26 4:11:33 PM ET
    $CTEV
    Real Estate
    Real Estate
    Get the next $CTEV alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Prince John Michael

    (Last)(First)(Middle)
    C/O CLARITEV CORPORATION
    7900 TYSONS ONE PLACE, SUITE 400

    (Street)
    MCLEAN VIRGINIA 22102

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Claritev Corp [ CTEV ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    04/29/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Class A common stock04/29/2026A(1)8,977A$021,662D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata based on the number of days of service provided to the issuer in the event of a voluntary resignation other than when grounds for termination for cause exist.
    Remarks:
    /s/ Kent Bartholomew, attorney-in-fact05/01/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $CTEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    5/29/2026$32.00Buy
    Canaccord Genuity
    4/24/2026$28.00Overweight
    Barclays
    1/12/2026$43.00Buy
    Guggenheim
    1/9/2026$33.00Equal Weight
    Wells Fargo
    10/21/2025$74.00Neutral → Buy
    Citigroup
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Claritev with a new price target

    Canaccord Genuity initiated coverage of Claritev with a rating of Buy and set a new price target of $32.00

    5/29/26 8:12:23 AM ET
    $CTEV
    Real Estate

    Barclays initiated coverage on Claritev with a new price target

    Barclays initiated coverage of Claritev with a rating of Overweight and set a new price target of $28.00

    4/24/26 8:04:36 AM ET
    $CTEV
    Real Estate

    Guggenheim initiated coverage on Claritev with a new price target

    Guggenheim initiated coverage of Claritev with a rating of Buy and set a new price target of $43.00

    1/12/26 8:12:35 AM ET
    $CTEV
    Real Estate

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Claritev Launches PHCS Novera to Give TPAs More Control Over Network Design Amid Rising Healthcare Costs

    New Primary Network Solution Helps Balance Regional Access, National Reach, and Cost Discipline As healthcare costs accelerate and employers demand more control over network strategy, Claritev Corporation (NYSE:CTEV), a healthcare technology, data and insights company, today announced the launch of PHCS Novera, a primary network solution designed to help deliver flexible, competitive options. With nearly two-thirds of covered workers enrolled in self-funded insurance plans and healthcare costs projected to rise 9.5% in 2026, employers are increasingly pushing third-party administrators (TPAs) to deliver more flexible, cost-conscious network designs. PHCS Novera was built to meet that de

    5/13/26 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors and host a presentation at the BofA Securities 2026 Global Health Care Conference in Las Vegas. The Company will webcast its presentation scheduled for 5:00 pm PT on Wednesday, May 13, 2026. To listen to the webcast, please visit https://investors.claritev.com/events-and-presentations/. For one-on-one meetings, please contact a representative at the host firm. About Claritev Claritev is a healthcare technology, data, and insights co

    5/11/26 8:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports First Quarter 2026 Results

    Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 Net Loss of $73.6 million Adjusted EBITDA of $146.9 million increased 3.4% compared to Q1 2025 (Adjusted EBITDA Margin of 60.0% versus 61.4% in Q1 2025) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026. "Claritev kicked off 2026 the same way we closed 2025, outperforming on the top and bottom lines with focused execution in sales, operations and financials. We are operating with confidence — confidence in our te

    5/7/26 6:00:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Digital Officer Kim Michael bought $49,950 worth of shares (3,000 units at $16.65), increasing direct ownership by 2% to 185,878 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/19/26 4:08:10 PM ET
    $CTEV
    Real Estate

    Director Prince John Michael bought $160,000 worth of shares (10,000 units at $16.00), increasing direct ownership by 46% to 31,662 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/19/26 4:07:57 PM ET
    $CTEV
    Real Estate

    Pres., CEO & Executive Chair Dalton Travis bought $258,638 worth of shares (20,920 units at $12.36) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/19/26 4:07:35 PM ET
    $CTEV
    Real Estate

    $CTEV
    SEC Filings

    View All

    Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Claritev Corp (0001793229) (Filer)

    5/18/26 12:00:30 PM ET
    $CTEV
    Real Estate

    SEC Form S-8 filed by Claritev Corporation

    S-8 - Claritev Corp (0001793229) (Filer)

    5/7/26 4:17:48 PM ET
    $CTEV
    Real Estate

    SEC Form 10-Q filed by Claritev Corporation

    10-Q - Claritev Corp (0001793229) (Filer)

    5/7/26 4:09:49 PM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Digital Officer Kim Michael bought $49,950 worth of shares (3,000 units at $16.65), increasing direct ownership by 2% to 185,878 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/19/26 4:08:10 PM ET
    $CTEV
    Real Estate

    Director Prince John Michael bought $160,000 worth of shares (10,000 units at $16.00), increasing direct ownership by 46% to 31,662 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/19/26 4:07:57 PM ET
    $CTEV
    Real Estate

    Pres., CEO & Executive Chair Dalton Travis bought $258,638 worth of shares (20,920 units at $12.36) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/19/26 4:07:35 PM ET
    $CTEV
    Real Estate

    $CTEV
    Leadership Updates

    Live Leadership Updates

    View All

    Claritev Releases 2024 Corporate Responsibility Report

    Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

    7/16/25 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

    Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

    5/28/25 8:00:00 AM ET
    $CTEV
    Real Estate

    Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

    HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

    5/6/25 10:02:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Financials

    Live finance-specific insights

    View All

    Claritev Corporation Reports First Quarter 2026 Results

    Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 Net Loss of $73.6 million Adjusted EBITDA of $146.9 million increased 3.4% compared to Q1 2025 (Adjusted EBITDA Margin of 60.0% versus 61.4% in Q1 2025) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026. "Claritev kicked off 2026 the same way we closed 2025, outperforming on the top and bottom lines with focused execution in sales, operations and financials. We are operating with confidence — confidence in our te

    5/7/26 6:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces First Quarter 2026 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter fiscal year 2026 financial results prior to market open on Thursday, May 7, 2026, and hold a conference call at 8:00 am Eastern Time. A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck

    4/20/26 8:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results

    Q4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year 2025 Revenues of $965.4 million (increase of 3.7% compared to FY 2024), Net loss of $284.3 million, and Adjusted EBITDA of $602.6 million (increase of 4.5% compared to FY 2024) Full-year 2026 Guidance initiated: Revenue range of $980 million to $1 billion Free cash flow of $0 million to $10 million Capital expenditures of $160 million to $170 million Company Board of Directors approves $75 million, five-year share repurchase program Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insigh

    2/23/26 4:05:00 PM ET
    $CTEV
    Real Estate